High-Risk Non-Muscle-Invasive Bladder Cancer—Therapy Options During Intravesical BCG Shortage

Bladder cancer is the second commonest urinary tract malignancy with 70–80 % being non-muscle invasive (NMIBC) at diagnosis. Patients with high-risk NMIBC (T1/Tis, with high grade/G3, or CIS) represent a challenging group as they are at greater risk of recurrence and progression. Intravesical Bacill...

Descripción completa

Detalles Bibliográficos
Autores principales: Veeratterapillay, Rajan, Heer, Rakesh, Johnson, Mark I., Persad, Raj, Bach, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Urosurgery (J Collins, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980405/
https://www.ncbi.nlm.nih.gov/pubmed/27492610
http://dx.doi.org/10.1007/s11934-016-0625-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980405/
https://www.ncbi.nlm.nih.gov/pubmed/27492610
http://dx.doi.org/10.1007/s11934-016-0625-z

Ejemplares similares